BAY 2666605
BAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 is a PDE3A-SLFN12 complex inducer (WO2019025562A1; example 135) [1].
Product Specifications
CAS Number
[2275774-60-0]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bay-2666605.html
Purity
99.74
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
FC(F)(C1=C(C2=CC=C(C=C2)F)C=CC(C([C@@H](O3)C)=NNC3=O)=C1)F
Molecular Formula
C17H12F4N2O2
Molecular Weight
352.28
References & Citations
[1]Manuel ELLERMANN, et al. Dihydrooxadiazinones. WO2019025562A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
PDE3
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4783704 1.0 µg DNA
Zcchc11 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details 
MBS1881304-01 0.05 mg
Biotinylated Anti-CCR8 (imzokitug biosimilar) mAb
Sign In for Pricing
View Details 
MBS1881304-02 0.1 mg
Biotinylated Anti-CCR8 (imzokitug biosimilar) mAb
Sign In for Pricing
View Details MBS1881304-03 5x 0.1 mg
Biotinylated Anti-CCR8 (imzokitug biosimilar) mAb
Sign In for Pricing
View Details MBS6282207-01 0.1 mL
CCNB2, Phosphorylated (T359) (Ccnb2, Cycb2, G2/mitotic-specific cyclin-B2) (MaxLight 490)
Sign In for Pricing
View Details